The landscape for patient access and value demonstration continues to evolve across Europe. Ongoing developments in health technology assessment (HTA), regulatory collaboration, and pharmaceutical policy are reshaping how innovative therapies reach patients. This track explores the opportunities and challenges created by these changes, while also looking ahead to emerging topics such as sustainability, environmental impact, and the role of new technologies in healthcare decision-making.

Who is This Track Designed For?

Value demonstration and patient access is relevant across different stakeholders. This track is designed for clinical, regulatory, patient, and value and market access experts who are interested in the link between technology innovators, regulatory, HTA and local decision-making, and how collaboration and engagement can improve patient access.

We invite abstracts containing multifunctional/multistakeholder perspectives (at a minimum Regulatory and Access perspectives) and gender balance is encouraged.